These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29025556)

  • 1. Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    Hernandez-Ojeda J; Arbelo E; Borras R; Berne P; Tolosana JM; Gomez-Juanatey A; Berruezo A; Campuzano O; Sarquella-Brugada G; Mont L; Brugada R; Brugada J
    J Am Coll Cardiol; 2017 Oct; 70(16):1991-2002. PubMed ID: 29025556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P
    J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator.
    Dores H; Reis Santos K; Adragão P; Moscoso Costa F; Galvão Santos P; Carmo P; Cavaco D; Bello Morgado F; Mendes M
    Rev Port Cardiol; 2015 Jun; 34(6):395-402. PubMed ID: 26028488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.
    Sacher F; Probst V; Iesaka Y; Jacon P; Laborderie J; Mizon-Gérard F; Mabo P; Reuter S; Lamaison D; Takahashi Y; O'Neill MD; Garrigue S; Pierre B; Jaïs P; Pasquié JL; Hocini M; Salvador-Mazenq M; Nogami A; Amiel A; Defaye P; Bordachar P; Boveda S; Maury P; Klug D; Babuty D; Haïssaguerre M; Mansourati J; Clémenty J; Le Marec H
    Circulation; 2006 Nov; 114(22):2317-24. PubMed ID: 17116772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up.
    Conte G; Dewals W; Sieira J; de Asmundis C; Ciconte G; Chierchia GB; Di Giovanni G; Baltogiannis G; Saitoh Y; Levinstein M; La Meir M; Wellens F; Pappaert G; Brugada P
    J Am Coll Cardiol; 2014 Jun; 63(21):2272-9. PubMed ID: 24681144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S; Uchiyama T; Komatsu Y; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Isobe M; Hirao K; Iesaka Y
    Am J Cardiol; 2013 May; 111(10):1448-51. PubMed ID: 23433764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Tassaneeyakul W; Sawanyawisuth K
    Singapore Med J; 2014 Apr; 55(4):217-20. PubMed ID: 24763838
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D; Roberts-Thomson KC; Inada K; Seiler J; Koplan BA; Tedrow UB; Sweeney MO; Epstein LE; Stevenson WG
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan.
    Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
    Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF).
    Leshem E; Rahkovich M; Mazo A; Suleiman M; Blich M; Laish-Farkash A; Konstantino Y; Fogelman R; Strasberg B; Geist M; Chetboun I; Swissa M; Ilan M; Glick A; Michowitz Y; Rosso R; Glikson M; Belhassen B
    Isr Med Assoc J; 2018 May; 20(5):269-276. PubMed ID: 29761670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.
    Casu G; Silva E; Bisbal F; Viola G; Merella P; Lorenzoni G; Motta G; Bandino S; Berne P
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1704-1711. PubMed ID: 33928706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Implantation in Patients With Brugada Syndrome.
    Dereci A; Yap SC; Schinkel AFL
    JACC Clin Electrophysiol; 2019 Feb; 5(2):141-148. PubMed ID: 30784682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.